Using a Smart Implantable Device to Compare Early Recovery in Two Different Knee Arthroplasty Approaches

January 9, 2026 updated by: Total Joint Specialists

Continuous Monitoring Using a Smart Implantable Device (Persona IQ®) to Compare Medial Parapatellar vs. Subvastus Approaches in Early Post-Operative Total Knee Arthroplasty Recovery

This is a single-institution, prospective, randomized study comparing the medial parapatellar and subvastus approaches in primary total knee arthroplasty using continuous, implant-based gait monitoring. Patients receiving a Zimmer Persona IQ smart implant will be followed preoperatively and through the first 30 days post-operatively, with extended follow-up to 6 months. Preoperative activity is captured using iPhone Health step-count data, while post-operative recovery is assessed using continuous tibial implant data, including step count, range of motion, cadence, walking speed, stride length, and distance. These objective metrics are correlated with PROMs. The primary outcome is daily step count. Secondary outcomes include early functional milestones, pain, and patient-reported functional scores. This study is designed to characterize early recovery trajectories and determine whether meaningful differences exist between surgical approaches.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Georgia
      • Sandy Springs, Georgia, United States, 30328
        • Total Joint Surgery Center Atlanta
        • Contact:
        • Contact:
        • Principal Investigator:
          • Thomas L Bradbury, M.D.
        • Sub-Investigator:
          • Zachary M Ricciardelli, B.S.
        • Sub-Investigator:
          • Charlotte C Baker, B.S.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • All patients older than 18 years of age who plan to undergo medial congruent polyethylene bearing primary TKA with a PIQ
  • Eligible for both approaches
  • Have an iPhone and willing to "wear" it for two weeks preoperatively to get an estimated average stepcount
  • Provide informed consent
  • Willing to complete follow ups

Exclusion Criteria:

  • Patients with TKA revisions
  • Patients with insufficient pre-operative range of motion in the operative knee (flexion contracture of > 20 degrees or < 90° of knee flexion)
  • Patients with Contralateral TKA within study time frame
  • Patients with TKA other than medial congruent polyethylene bearing
  • Patients with bilateral surgery
  • Patients without a valid and active email address
  • Patients not willing or able to participate in study and follow-ups
  • Patients who use assisted devices to ambulate
  • Rheumatoid arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Medial Parapatellar Approach
Primary total knee arthroplasty performed using the medial parapatellar surgical approach
Incision splitting quad
Active Comparator: Subvastus Approach
Primary total knee arthroplasty performed using the subvastus surgical approach
quad-sparing approach

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Step Count (steps/day)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Step Count (steps/day)
Time Frame: Baseline
Recorded from patients iPhone Health App for 2 weeks preoperatively
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stride Length (m)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Distance Travelled (km)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Functional Range of Motion (degrees)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Tibial Range of Motion (degrees)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Cadence (steps/minute)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Walking Speed (m/s)
Time Frame: Through study completion, minimum 6 months
Continuously recorded from PIQ device after it is implanted during surgery
Through study completion, minimum 6 months
Goniometric Functional Range of Motion
Time Frame: Preoperatively and at 6 weeks
Measured in degrees using a goniometer
Preoperatively and at 6 weeks
Surgical Side
Time Frame: Preoperatively
Left or Right
Preoperatively
Age
Time Frame: Preoperatively
In years, from EMR
Preoperatively
Sex
Time Frame: Preoperatively
Male or Female, from EMR
Preoperatively
Weight
Time Frame: Preoperatively
In kg, from EMR
Preoperatively
Height
Time Frame: Preoperatively
In cm, from EMR
Preoperatively
Body Mass Index (BMI)
Time Frame: Preoperatively
in kg/m2, from EMR
Preoperatively
Comorbidities
Time Frame: Preoperatively
Collected and listed from EMR
Preoperatively
Charlson Comorbidity Index (CCI)
Time Frame: Preoperatively
Calculated from formula using comorbidities collected from EMR
Preoperatively
Time to Achieving Key Milestones in Daily Activities
Time Frame: 6 weeks postoperatively
Survey score collected (less time = better), Survey via Force Therapeutics
6 weeks postoperatively
Veterans Rand 12-Item (VR-12) Health Survey
Time Frame: Preoperatively, 6 weeks postoperatively, 6 months postoperatively
Mental and Physical component survey scores collected (0-100); Survey via Force Therapeutics
Preoperatively, 6 weeks postoperatively, 6 months postoperatively
Procedure Satisfaction
Time Frame: 6 weeks postoperatively
Survey score collected (0-5; 5 best), Survey via Force Therapeutics
6 weeks postoperatively
Numeric Pain Rating Scale (NPRS)
Time Frame: Preoperatively, 6 weeks postoperatively
Survey score collected (0-10; 0 best), Survey via Force Therapeutics
Preoperatively, 6 weeks postoperatively
Knee injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR.)
Time Frame: Preoperatively, 6 weeks postoperatively, 6 months postoperatively
Survey score collected (0-100; 100 best), Survey via Force Therapeutics
Preoperatively, 6 weeks postoperatively, 6 months postoperatively
Forgotten Joint Score (FJS)
Time Frame: Preoperatively, 6 weeks postoperatively, 6 months postoperatively
Survey score collected (0-100; 100 best), Survey via Force Therapeutics
Preoperatively, 6 weeks postoperatively, 6 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2026

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2027

Study Registration Dates

First Submitted

December 15, 2025

First Submitted That Met QC Criteria

January 9, 2026

First Posted (Estimated)

January 16, 2026

Study Record Updates

Last Update Posted (Estimated)

January 16, 2026

Last Update Submitted That Met QC Criteria

January 9, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will only be used as necessary by the authorized research team and always secured, it will not be shared

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Knee Anthroplasty

Clinical Trials on Total Knee Arthroplasty Medial Parapatellar Approach

Subscribe